July 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]Read More
October 2010 source: Medical Device & Diagnostic Industry online The MX Q&A: Ted Driscoll, Claremont Creek Ventures Fledgling device companies can get a leg up with VC firms by developing a product that is ‘unique and protectable,’ says Tibion’s anchor investor. The cofounders of Tibion Bionic Technologies may want to send a thank-you note to […]Read More
October 20, 2010 source: San Francisco Chronicle Business Report “With the help of a physical therapist, Micha Hoy strapped a big black computer-controlled device onto her left leg, which has had limited mobility since she experienced a stroke nine years ago. “I feel like I should be in the ‘Matrix’ movies,” the San Francisco architect […]Read More
August 10, 2010 source: Send2Press Newswire DAVIS, Calif., Aug. 10 (SEND2PRESS NEWSWIRE) — California IVF: Davis Fertility Center, Inc. (californiaivf.com), working in conjunction with Gene Security Network (genesecurity.net) leads the field in bringing a new test to patients that combines the detection of single-gene genetic disorders with a 24 chromosome screening. Using Gene Security Network’s […]Read More
July 13, 2010 source: VentureBeat Tibion Bionic Technologies, a startup that develops orthopedic devices to help patients regain mobility, has closed a $3 million round of equity, according to a filing with the SEC. The company’s knee technologies can be used during physical therapy to help patients dealing with a stroke, multiple sclerosis, Parkinson’s disease […]Read More
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.